{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T13:54:44Z","timestamp":1766066084456},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"S7","license":[{"start":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T00:00:00Z","timestamp":1312502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2105-12-s7-a10","type":"journal-article","created":{"date-parts":[[2011,8,6]],"date-time":"2011-08-06T18:23:05Z","timestamp":1312654985000},"source":"Crossref","is-referenced-by-count":15,"title":["PharmacoMicrobiomics or how bugs modulate drugs: an educational initiative to explore the effects of human microbiome on drugs"],"prefix":"10.1186","volume":"12","author":[{"given":"Ramy K","family":"Aziz","sequence":"first","affiliation":[]},{"given":"Rama","family":"Saad","sequence":"additional","affiliation":[]},{"given":"Mariam R","family":"Rizkallah","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"4694_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/03602530801952864","volume":"40","author":"DW Nebert","year":"2008","unstructured":"Nebert DW, Zhang G, Vesell ES: From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 2008, 40: 187\u2013224. 10.1080\/03602530801952864","journal-title":"Drug Metab Rev"},{"key":"4694_CR2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nature06244","volume":"449","author":"PJ Turnbaugh","year":"2007","unstructured":"Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI: The human microbiome project. Nature 2007, 449: 804\u2013810. 10.1038\/nature06244","journal-title":"Nature"},{"key":"4694_CR3","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1101\/gr.096651.109","volume":"19","author":"J Peterson","year":"2009","unstructured":"Peterson J, Garges S, Giovanni M, McInnes P, Wang L, Schloss JA, Bonazzi V, McEwen JE, Wetterstrand KA, Deal C, et al.: The NIH Human Microbiome Project. Genome Res 2009, 19: 2317\u20132323. 10.1101\/gr.096651.109","journal-title":"Genome Res"},{"key":"4694_CR4","doi-asserted-by":"publisher","first-page":"14728","DOI":"10.1073\/pnas.0904489106","volume":"106","author":"TA Clayton","year":"2009","unstructured":"Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK: Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 2009, 106: 14728\u201314733. 10.1073\/pnas.0904489106","journal-title":"Proc Natl Acad Sci USA"},{"key":"4694_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.2174\/138161209788168173","volume":"15","author":"ID Wilson","year":"2009","unstructured":"Wilson ID, Nicholson JK: The role of gut microbiota in drug response. Curr Pharm Des 2009, 15: 1519\u20131523. 10.2174\/138161209788168173","journal-title":"Curr Pharm Des"},{"key":"4694_CR6","doi-asserted-by":"publisher","first-page":"14187","DOI":"10.1073\/pnas.0907721106","volume":"106","author":"ID Wilson","year":"2009","unstructured":"Wilson ID: Drugs, bugs, and personalized medicine: pharmacometabonomics enters the ring. Proc Natl Acad Sci USA 2009, 106: 14187\u201314188.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4694_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2174\/187569210792246326","volume":"8","author":"M Rizkallah","year":"2010","unstructured":"Rizkallah M, Saad R, Aziz R: The Human Microbiome Project, personalized medicine and the birth of pharmacomicrobiomics. Cur Pharmacog Personalized Med (Formerly Current Pharmacog) 2010, 8: 182\u2013193.","journal-title":"Cur Pharmacog Personalized Med (Formerly Current Pharmacog)"},{"key":"4694_CR8","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1211\/0022357001777621","volume":"52","author":"T Akao","year":"2000","unstructured":"Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, Sakashita Y, Kobashi K: Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharm Pharmacol 2000, 52: 1563\u20131568. 10.1211\/0022357001777621","journal-title":"J Pharm Pharmacol"},{"key":"4694_CR9","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/gut.30.7.971","volume":"30","author":"VI Mathan","year":"1989","unstructured":"Mathan VI, Wiederman J, Dobkin JF, Lindenbaum J: Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora. Gut 1989, 30: 971\u2013977. 10.1136\/gut.30.7.971","journal-title":"Gut"},{"key":"4694_CR10","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/jn\/133.6.1853","volume":"133","author":"MP Gonthier","year":"2003","unstructured":"Gonthier MP, Verny MA, Besson C, Remesy C, Scalbert A: Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 2003, 133: 1853\u20131859.","journal-title":"J Nutr"},{"key":"4694_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0278-6915(03)00010-3","volume":"41","author":"EF Lhoste","year":"2003","unstructured":"Lhoste EF, Ouriet V, Bruel S, Flinois JP, Brezillon C, Magdalou J, Cheze C, Nugon-Baudon L: The human colonic microflora influences the alterations of xenobiotic-metabolizing enzymes by catechins in male F344 rats. Food Chem Toxicol 2003, 41: 695\u2013702. 10.1016\/S0278-6915(03)00010-3","journal-title":"Food Chem Toxicol"},{"key":"4694_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.2042-7158.1997.tb06790.x","volume":"49","author":"S Kitamura","year":"1997","unstructured":"Kitamura S, Sugihara K, Kuwasako M, Tatsumi K: The role of mammalian intestinal bacteria in the reductive metabolism of zonisamide. J Pharm Pharmacol 1997, 49: 253\u2013256. 10.1111\/j.2042-7158.1997.tb06790.x","journal-title":"J Pharm Pharmacol"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-S7-A10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2105-12-S7-A10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-S7-A10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T10:33:55Z","timestamp":1548239635000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-12-S7-A10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,5]]},"references-count":12,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["4694"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-12-s7-a10","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,5]]},"article-number":"A10"}}